MX2007003337A - Derivado de amina ciclica o sal del mismo. - Google Patents
Derivado de amina ciclica o sal del mismo.Info
- Publication number
- MX2007003337A MX2007003337A MX2007003337A MX2007003337A MX2007003337A MX 2007003337 A MX2007003337 A MX 2007003337A MX 2007003337 A MX2007003337 A MX 2007003337A MX 2007003337 A MX2007003337 A MX 2007003337A MX 2007003337 A MX2007003337 A MX 2007003337A
- Authority
- MX
- Mexico
- Prior art keywords
- salt
- amine derivative
- dihydro
- disease
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Abstract
Un compuesto util como un antagonista de NMDA teniendo una amplia region de seguridad que es un agente terapeutico para enfermedad de Alzheimer, demencia vascular (agnosis vascular), enfermedad de Parkinson, apoplejia isquemica, y dolores o un agente de prevencion para estos. El compuesto es un derivado de amina o sal del mismos carcterizado por comprender una estructura que contiene amina (A) y un amplio fusionado di-o triciclico (indano, tetralona, 4,5,6,7-tetrahidrobenzotiofeno, 4,5,,6,7- tetrahidrobenzofuran, 7,8-dihidro6H-indeno [4,5-b]furan, 2,3-dihidro1h-ciclopenta [a]naftaleno, etc) unido a la estructura (A) a traves de X1 (un enlace, alquileno inferior, etc). El antagonista de NMDA contiene el derivado o sal como un ingrediente activo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004274105 | 2004-09-21 | ||
PCT/JP2005/017272 WO2006033318A1 (ja) | 2004-09-21 | 2005-09-20 | 環状アミン誘導体又はその塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007003337A true MX2007003337A (es) | 2007-05-21 |
Family
ID=36090077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007003337A MX2007003337A (es) | 2004-09-21 | 2005-09-20 | Derivado de amina ciclica o sal del mismo. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070197594A1 (es) |
EP (1) | EP1795524A4 (es) |
JP (1) | JP4748320B2 (es) |
KR (1) | KR20070064437A (es) |
CN (1) | CN101023055B (es) |
AU (1) | AU2005285878B2 (es) |
BR (1) | BRPI0515525A (es) |
CA (1) | CA2580980C (es) |
IL (1) | IL181897A (es) |
MX (1) | MX2007003337A (es) |
NO (1) | NO20072036L (es) |
RU (1) | RU2347776C2 (es) |
TW (1) | TW200621677A (es) |
WO (1) | WO2006033318A1 (es) |
ZA (1) | ZA200702333B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8013018B2 (en) * | 2006-07-18 | 2011-09-06 | Astellas Pharma Inc. | Aminoindane derivative or salt thereof |
WO2008064342A2 (en) * | 2006-11-21 | 2008-05-29 | Omeros Corporation | Pde10 inhibitors and related compositions and methods |
US7786139B2 (en) | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
BRPI0819795B8 (pt) * | 2007-11-28 | 2021-05-25 | Astellas Pharma Inc | compostos de indano fundidos e seus usos no tratamento de doenças relacionadas ao receptor nmda, bem como composição farmacêutica compreendendo os mesmos |
US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8546377B2 (en) * | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
RU2014147175A (ru) | 2009-05-22 | 2015-06-27 | Эббви Инк. | Модуляторы рецепторов 5-нт и способы их применения |
WO2011101774A1 (en) | 2010-02-16 | 2011-08-25 | Pfizer Inc. | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
RU2015140748A (ru) | 2010-05-21 | 2018-12-26 | Эббви Инк. | Модуляторы 5-нт рецепторов и способы их применения |
AR092924A1 (es) | 2012-10-09 | 2015-05-06 | Sanofi Sa | Derivados de pirrolidinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados |
WO2018230776A1 (ko) * | 2017-06-16 | 2018-12-20 | 주식회사 코팜 | 프테로신 화합물 및 이의 유도체를 유효성분으로 포함하는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
KR102085358B1 (ko) * | 2017-06-21 | 2020-03-05 | 고려대학교 산학협력단 | 프테로신 화합물 및 이의 유도체를 유효성분으로 포함하는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
JP7264158B2 (ja) | 2018-03-30 | 2023-04-25 | 東レ株式会社 | 神経細胞内カルシウム濃度上昇抑制剤 |
CN110357339B (zh) * | 2019-08-14 | 2021-08-31 | 盛隆资源再生(无锡)有限公司 | 一种利用高氟高氨氮废水连续生产氟化钠的方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470055A1 (de) * | 1963-12-07 | 1969-07-17 | Merck Ag E | Verfahren zur Herstellung von Piperidinderivaten |
CH647235A5 (de) * | 1980-02-13 | 1985-01-15 | Sandoz Ag | 4-(2,2-dialkylindan-1-yliden)piperidin derivate, ihre herstellung und verwendung. |
IE55972B1 (en) * | 1982-10-07 | 1991-03-13 | Kefalas As | Phenylindene derivatives,acid addition salts thereof,and methods of preparation |
DE58905637D1 (de) * | 1989-04-14 | 1993-10-21 | Merz & Co Gmbh & Co | Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie. |
US5703239A (en) * | 1995-06-02 | 1997-12-30 | Bristol-Myers Squibb Company | Indanylpiperidines as melatonergic agents |
CA2220649C (en) * | 1996-12-03 | 2007-02-13 | F. Hoffmann-La Roche Ag | 4-hydroxy-piperidine derivatives |
US6071966A (en) * | 1997-06-30 | 2000-06-06 | Merz + Co. Gmbh & Co. | 1-amino-alkylcyclohexane NMDA receptor antagonists |
EA002254B1 (ru) * | 1997-06-30 | 2002-02-28 | Мерц + Ко. Гмбх Унд Ко. | 1-аминоалкилциклогексановые антагонисты рецепторов nmda |
ATE306482T1 (de) * | 1999-07-28 | 2005-10-15 | Ortho Mcneil Pharm Inc | Amine and amide als ligande für den neuropeptid-y y5 rezeptor, und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen |
DE10050236A1 (de) * | 2000-10-11 | 2002-04-25 | Merck Patent Gmbh | Verwendung bestimmter Substanzen, die an den Sigma-Rezeptor binden, zur Behandlung von Sarkomen und Karzinomen |
ATE527247T1 (de) * | 2001-07-05 | 2011-10-15 | Takeda Pharmaceutical | Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung |
JP4357802B2 (ja) * | 2001-07-05 | 2009-11-04 | 武田薬品工業株式会社 | ベンゼン環縮合5員複素環式化合物、その製造法および用途 |
-
2005
- 2005-09-19 TW TW094132339A patent/TW200621677A/zh not_active IP Right Cessation
- 2005-09-20 MX MX2007003337A patent/MX2007003337A/es active IP Right Grant
- 2005-09-20 ZA ZA200702333A patent/ZA200702333B/xx unknown
- 2005-09-20 BR BRPI0515525-8A patent/BRPI0515525A/pt not_active IP Right Cessation
- 2005-09-20 RU RU2007115093/04A patent/RU2347776C2/ru not_active IP Right Cessation
- 2005-09-20 AU AU2005285878A patent/AU2005285878B2/en not_active Ceased
- 2005-09-20 CA CA2580980A patent/CA2580980C/en not_active Expired - Fee Related
- 2005-09-20 EP EP05785275A patent/EP1795524A4/en not_active Withdrawn
- 2005-09-20 WO PCT/JP2005/017272 patent/WO2006033318A1/ja active Application Filing
- 2005-09-20 JP JP2006536375A patent/JP4748320B2/ja not_active Expired - Fee Related
- 2005-09-20 CN CN2005800318437A patent/CN101023055B/zh not_active Expired - Fee Related
- 2005-09-20 KR KR1020077009040A patent/KR20070064437A/ko active IP Right Grant
- 2005-09-20 US US11/663,628 patent/US20070197594A1/en not_active Abandoned
-
2007
- 2007-03-13 IL IL181897A patent/IL181897A/en not_active IP Right Cessation
- 2007-04-20 NO NO20072036A patent/NO20072036L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL181897A (en) | 2012-05-31 |
AU2005285878B2 (en) | 2011-06-30 |
RU2007115093A (ru) | 2008-11-10 |
JPWO2006033318A1 (ja) | 2008-05-15 |
CN101023055A (zh) | 2007-08-22 |
JP4748320B2 (ja) | 2011-08-17 |
EP1795524A4 (en) | 2009-08-05 |
US20070197594A1 (en) | 2007-08-23 |
CA2580980A1 (en) | 2006-03-30 |
KR20070064437A (ko) | 2007-06-20 |
CN101023055B (zh) | 2010-10-06 |
TWI337988B (es) | 2011-03-01 |
EP1795524A1 (en) | 2007-06-13 |
ZA200702333B (en) | 2009-05-27 |
RU2347776C2 (ru) | 2009-02-27 |
BRPI0515525A (pt) | 2008-08-05 |
NO20072036L (no) | 2007-05-23 |
IL181897A0 (en) | 2007-07-04 |
AU2005285878A1 (en) | 2006-03-30 |
TW200621677A (en) | 2006-07-01 |
CA2580980C (en) | 2011-05-03 |
WO2006033318A1 (ja) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007003337A (es) | Derivado de amina ciclica o sal del mismo. | |
ES2159491A1 (es) | Base cristalina de citalopram | |
HK1084941A1 (en) | Compounds and their use | |
ATE548031T1 (de) | Inhibitoren gegen die produktion und freisetzung entzündungfördernder zytokine | |
BR0213464A (pt) | Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide | |
ID26128A (id) | Senyawa-senyawa aminotetralin tersubstitusi-n sebagai ligan-ligan untuk reseptor neupeptida y y5 yang bermanfaat dalam pengobatan obesitas dan gangguan-gangguan lain | |
MY141559A (en) | Triazole derivatives as tachykinin receptor antagonists | |
MY143987A (en) | Constrained himbacine analogs as thrombin receptor antagonists | |
WO2005030712A3 (en) | Thrombin receptor antagonists | |
MX2012005994A (es) | Compuestos de 2-piridona. | |
RS53521B1 (en) | PREPARATION AND THERAPY APPLICATIONS (2S, 3R) -N-2 - ((3-pyridinyl) methyl) -1-AZABICYCLO [2.2.2] OCT-3-IL) -3,5-DIFLUOROBENZAMIDE | |
EA200200952A1 (ru) | Производные циклогексиламина в качестве селективных антагонистов подтипов nmda-рецепторов | |
WO2001096307A3 (en) | Cycloalkyl alkanoic acids as integrin receptor antagonists | |
BRPI0519709A2 (pt) | derivados de tetralina e indano e usos dos mesmos como antagonistas de 5-ht | |
NO20021799D0 (no) | Nye cyklopropaner som CGRP-antagonister, legemidler som inneholder disse forbindelser og fremgangsmåte for deresfremstilling | |
WO2002060423A3 (en) | Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists | |
MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
BG66086B1 (bg) | Кристална база на есциталопрам, негови соли и метод за получаване | |
DK0622077T3 (da) | Angiotensin-II-antagonister som profylaktisk eller terapeutisk middel til nyresygdomme | |
EA200201158A1 (ru) | Бициклические циклогексиламины и их применение в качестве антагонистов nmda-рецепторов | |
NO20080671L (no) | Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister | |
WO2003018515A3 (en) | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders | |
DE60112725D1 (de) | Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors | |
AU2003281468A1 (en) | P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient | |
Malomvolgyi et al. | Comparison of serotonin agonistic and antagonistic activities of a new antidepressant agent Trelibet (EGYT-475) and its metabolite EGYT-2760 on isolated rat fundus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |